Cargando…

Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study

Guidelines vary for the age at which to begin breast cancer screening and the interval between examinations. A validated computer model was used to compare estimated outcomes between various screening regimens. The OncoSim-Breast microsimulation model (Canadian Partnership Against Cancer) was used t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaffe, Martin J., Mainprize, James G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670884/ https://www.ncbi.nlm.nih.gov/pubmed/37999106 http://dx.doi.org/10.3390/curroncol30110686

Ejemplares similares

The Value of All-Cause Mortality as a Metric for Assessing Breast Cancer Screening
por: Yaffe, Martin J, et al.
Publicado: (2020)

Overdetection of Breast Cancer
por: Yaffe, Martin J., et al.
Publicado: (2022)

Investigating the feasibility of stratified breast cancer screening using a masking risk predictor
por: Alonzo-Proulx, Olivier, et al.
Publicado: (2019)

External validation of a mammographic texture marker for breast cancer risk in a case–control study
por: Wang, Chao, et al.
Publicado: (2020)

Effects of ionizing radiation exposure during pregnancy
por: Mainprize, James G., et al.
Publicado: (2023)

Correction for Self-Selection in Breast Cancer Screening. Comment on Dibden et al. Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality. Cancers 2020, 12, 976
por: Yaffe, Martin J.
Publicado: (2023)

The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada
por: Yong, Jean HE, et al.
Publicado: (2020)

Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing
por: Wilkinson, Anna N., et al.
Publicado: (2023)

Mammographic features associated with interval breast cancers in screening programs
por: Boyd, Norman F, et al.
Publicado: (2014)

Outcome of breast cancer screening in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2017)

The OncoSim-Breast Cancer Microsimulation Model
por: Yong, Jean H. E., et al.
Publicado: (2022)

Breast cancer screening outcomes among Mexican-origin Hispanic women participating in a breast cancer screening program
por: Winters, Stella, et al.
Publicado: (2021)

The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients
por: Butler-Xu, Yiqing Shirley, et al.
Publicado: (2018)

Evidence That Breast Tissue Stiffness Is Associated with Risk of Breast Cancer
por: Boyd, Norman F., et al.
Publicado: (2014)

Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2018)

Immunotherapy for Breast Cancer: First FDA Approved Regimen
por: Soare, Georgiana R., et al.
Publicado: (2019)

Mammographic density and breast cancer risk: current understanding and future prospects
por: Boyd, Norman F, et al.
Publicado: (2011)

Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening
por: Román, M, et al.
Publicado: (2017)

Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers
por: Niraula, Saroj, et al.
Publicado: (2020)

A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model
por: Brentnall, Adam R, et al.
Publicado: (2019)

Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
por: Ávila-Arroyo, Sonia, et al.
Publicado: (2015)

A systematic review of taxane-containing regimens for metastatic breast cancer
por: Ghersi, D, et al.
Publicado: (2005)

Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer
por: Vaid, Ashok K., et al.
Publicado: (2020)

Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study
por: Allgood, P C, et al.
Publicado: (2006)

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
por: Humphreys, Samantha, et al.
Publicado: (2013)

The cardiotoxicity effect of different chemotherapeutic regimens in Iraqi patients with breast cancer: A follow up study
por: Anber, Zainab Nazar Hasan, et al.
Publicado: (2019)

Outcomes by Race in Breast Cancer Screening With Digital Breast Tomosynthesis Versus Digital Mammography
por: Alsheik, Nila, et al.
Publicado: (2021)

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening
por: Duijm, L E M, et al.
Publicado: (2004)

Different treatment regimens in breast cancer visceral crisis: A retrospective cohort study
por: Yang, Ruohan, et al.
Publicado: (2022)

Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer
por: Barroso‐Sousa, Romualdo, et al.
Publicado: (2021)

Breast cancer screening
por: Chala, Luciano Fernandes, et al.
Publicado: (2023)

A Case Control Study on the Effectiveness of Breast Cancer Screening by Clinical Breast Examination in Japan
por: Kanemura, Seiki, et al.
Publicado: (1999)

The Effect of California’s Breast Density Notification Legislation on Breast Cancer Screening
por: Chau, Stephanie Lynn, et al.
Publicado: (2016)

Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway
por: Louro, Javier, et al.
Publicado: (2023)

Comparing the Gonadotoxicity of Multiple Breast Cancer Regimens: Important Understanding for Managing Breast Cancer in Pre-Menopausal Women
por: Martelli, Valentino, et al.
Publicado: (2021)

Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis
por: Ghafouri, Sanaz N., et al.
Publicado: (2022)

Impact of the age expansion of breast screening on screening uptake and screening outcomes among older women in BreastScreen western
por: El-Zaemey, Sonia, et al.
Publicado: (2021)

The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program
por: Wang, Jing, et al.
Publicado: (2020)

Limitations in the Effect of Screening on Breast Cancer Mortality
por: Beau, Anna-Belle, et al.
Publicado: (2018)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b25nevt32n2o8jjqu8pg6n1bs4